Baxter and B. Braun have notified ASPEN that some of their amino
acids products are on allocation. For
more information on these allocations please see Baxter’s and
B. Braun’s Valued
Customer Letters. ASPEN has developed shortage considerations for parenteral
amino acids products to assist its members and other clinicians in coping with shortages for their patients. Some of the considerations
for managing a shortage of amino acids include:
- Assess
and regularly reassess each patient as to the indication for PN and
provide nutrition via the oral or enteral route when possible.
-
ONLY
use Neonatal/Pediatric-specific amino acids or disease-specific amino acids for
the indicated patient populations.
- Reserve
high concentration amino acids products (e.g., greater than 10%) for
fluid-restricted patients requiring PN.
- Assess your PN patient
population to determine if multi-chamber bag PN products (aka, standardized,
commercially-available parenteral nutrition products) may be
appropriate for a portion of your patient population.
- Compound PN in a single, central location (either in a centralized
pharmacy or as outsourced preparation) to decrease inventory waste.
Consider a supply outreach to other facilities in your geographic
location.